NYSE:FUL - HB Fuller Stock Price, News, & Analysis

HB Fuller trades on the New York Stock Exchange (NYSE) under the ticker symbol "FUL."

HB Fuller announced a quarterly dividend on Thursday, April 4th. Investors of record on Thursday, April 18th will be paid a dividend of $0.16 per share on Thursday, May 2nd. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date of this dividend is Wednesday, April 17th. This is a boost from HB Fuller's previous quarterly dividend of $0.16. View HB Fuller's Dividend History.

HB Fuller Co (NYSE:FUL) issued its quarterly earnings results on Wednesday, March, 27th. The specialty chemicals company reported $0.34 EPS for the quarter, hitting the consensus estimate of $0.34. The specialty chemicals company earned $673 million during the quarter, compared to the consensus estimate of $697.64 million. HB Fuller had a return on equity of 13.53% and a net margin of 4.52%. The company's revenue for the quarter was down 5.6% compared to the same quarter last year. View HB Fuller's Earnings History.

HB Fuller is scheduled to release their next quarterly earnings announcement on Wednesday, June 26th 2019. View Earnings Estimates for HB Fuller.

HB Fuller will be holding an earnings conference call on Thursday, June 27th at 10:30 AM Eastern. Interested parties can register for or listen to the call using this link.

HB Fuller updated its FY19 earnings guidance on Wednesday, March, 27th. The company provided earnings per share (EPS) guidance of $3.15 to $3.45 for the period, compared to the Thomson Reuters consensus estimate of $3.28.

5 brokers have issued 1-year price targets for HB Fuller's stock. Their forecasts range from $50.00 to $65.00. On average, they expect HB Fuller's stock price to reach $56.5580 in the next year. This suggests a possible upside of 29.9% from the stock's current price. View Analyst Price Targets for HB Fuller.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HB Fuller in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for HB Fuller.

Media coverage about FUL stock has trended somewhat positive this week, according to InfoTrie. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. HB Fuller earned a news sentiment score of 1.4 on InfoTrie's scale. They also gave media stories about the specialty chemicals company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for HB Fuller.

Some companies that are related to HB Fuller include South32 (S32), Mosaic (MOS), Antofagasta (ANTO), Kingspan Group (KGP), THYSSENKRUPP AG/S (TKAMY), ThyssenKrupp (TYEKF), MONDI PLC/ADR (MONDY), Sociedad Quimica y Minera de Chile (SQM), Westlake Chemical (WLK), Bunge (BG), Stora Enso Oyj (SEOAY), Inter Pipeline (IPL), Croda International (COIHD), JFE (JFEEF) and Kirkland Lake Gold (KL).

Based on aggregate information from My MarketBeat watchlists, some companies that other HB Fuller investors own include MCCORMICK & CO /SH (MKC), Raytheon (RTN), U.S. Silica (SLCA), Exxon Mobil (XOM), Broadcom (AVGO), Air Products & Chemicals (APD), Alibaba Group (BABA), Cardinal Health (CAH), CVS Health (CVS) and Home Depot (HD).

HB Fuller's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (14.84%), Janus Henderson Group PLC (5.60%), Principal Financial Group Inc. (4.39%), Champlain Investment Partners LLC (3.16%), Gamco Investors INC. ET AL (1.13%) and Gabelli Funds LLC (0.98%). Company insiders that own HB Fuller stock include Dietrich J Crail, Heather Campe, John J Corkrean, Robert J Martsching, Sant R William Van, Steven Kenny, Timothy J Keenan and Traci L Jensen. View Institutional Ownership Trends for HB Fuller.

FUL stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Champlain Investment Partners LLC, Principal Financial Group Inc., Marshall Wace LLP, Phocas Financial Corp., Wedge Capital Management L L P NC, Kennedy Capital Management Inc. and California Public Employees Retirement System. Company insiders that have sold HB Fuller company stock in the last year include Heather Campe, Robert J Martsching, Sant R William Van, Steven Kenny, Timothy J Keenan and Traci L Jensen. View Insider Buying and Selling for HB Fuller.

FUL stock was bought by a variety of institutional investors in the last quarter, including State of Wisconsin Investment Board, BlackRock Inc., Arizona State Retirement System, Penn Capital Management Co. Inc., Pennsylvania Trust Co, Raymond James & Associates, Menta Capital LLC and S&CO Inc.. Company insiders that have bought HB Fuller stock in the last two years include Dietrich J Crail and John J Corkrean. View Insider Buying and Selling for HB Fuller.

Shares of FUL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of FUL stock can currently be purchased for approximately $43.53.

HB Fuller has a market capitalization of $2.22 billion and generates $3.04 billion in revenue each year. The specialty chemicals company earns $171.20 million in net income (profit) each year or $3.00 on an earnings per share basis. HB Fuller employs 6,479 workers across the globe.View Additional Information About HB Fuller.

The official website for HB Fuller is http://www.hbfuller.com/.

HB Fuller's mailing address is 1200 WILLOW LAKE BLVD, ST PAUL MN, 55110. The specialty chemicals company can be reached via phone at 651-236-5900 or via email at [email protected]